Ingenol mebutate (Picato) topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults
The objective of this systematic review is to examine the beneficial and harmful effects of ingenol mebutate once daily for the topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (AK) for the face and scalp (0.015% gel, three-day treatment) and for the trunk and extremities...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2014, 2014
|
| Series: | Common drug review clinical review report
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of this systematic review is to examine the beneficial and harmful effects of ingenol mebutate once daily for the topical treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (AK) for the face and scalp (0.015% gel, three-day treatment) and for the trunk and extremities (0.05% gel, two-day treatment) in adult patients |
|---|---|
| Item Description: | Title from title screen. - "February 2014." |
| Physical Description: | 1 online resource illustrations |